Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-31 @ 6:33 PM
Study NCT ID:
NCT06387056
Status:
RECRUITING
Last Update Posted:
2024-04-26
First Post:
2024-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
Sponsor:
The First Affiliated Hospital of Xiamen University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
XMYY-2024KY040
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None